Feletto et al. [7] in their recent study compared the incidence and mortality rates of PCa in Australia, USA, Canada and England, and demonstrated that incidence rates in these countries are likely to be heavily influenced by prostate-specific antigen (PSA) testing, and that there was a fall in mortality that occurred too soon to be solely a result of testing. Here, KLK3 is linked to posterior cortical atrophy.